These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9824647)

  • 1. The (-)-enantiomer of gossypol inhibits proliferation of stromal cells derived from human breast adipose tissues by enhancing transforming growth factor beta1 production.
    Zhang Y; Kulp SK; Sugimoto Y; Brueggemeier RW; Lin YC
    Int J Oncol; 1998 Dec; 13(6):1291-7. PubMed ID: 9824647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
    Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC
    Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer.
    Liu S; Kulp SK; Sugimoto Y; Jiang J; Chang HL; Dowd MK; Wan P; Lin YC
    Anticancer Res; 2002; 22(1A):33-8. PubMed ID: 12017312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor-beta1.
    Zhou W; Park I; Pins M; Kozlowski JM; Jovanovic B; Zhang J; Lee C; Ilio K
    Endocrinology; 2003 Oct; 144(10):4280-4. PubMed ID: 12959966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of transforming growth factor-beta (TGF beta) isoforms and TGF beta type II receptor messenger ribonucleic acid and protein, and the effect of TGF beta s on endometrial stromal cell growth and protein degradation in vitro.
    Tang XM; Zhao Y; Rossi MJ; Abu-Rustum RS; Ksander GA; Chegini N
    Endocrinology; 1994 Jul; 135(1):450-9. PubMed ID: 8013384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RU486 is a potent inhibitor of aromatase induction in human breast adipose tissue stromal cells.
    Schmidt M; Löffler G
    J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):197-204. PubMed ID: 9191977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human prostate cancer cells growth by gossypol is associated with stimulation of transforming growth factor-beta.
    Shidaifat F; Canatan H; Kulp SK; Sugimoto Y; Chang WY; Zhang Y; Brueggemeier RW; Somers WJ; Lin YC
    Cancer Lett; 1996 Oct; 107(1):37-44. PubMed ID: 8913264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of proliferation, motility, and contractivity of cultured human endometrial stromal cells by transforming growth factor-beta isoforms.
    Nasu K; Nishida M; Matsumoto H; Bing S; Inoue C; Kawano Y; Miyakawa I
    Fertil Steril; 2005 Oct; 84 Suppl 2():1114-23. PubMed ID: 16210002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase expression in leptin-pretreated human breast pre-adipocytes is enhanced by zeranol and suppressed by (-)-gossypol.
    Zhong S; Ye WP; Xu PP; Feng E; Li H; Lin SH; Liu JY; Ma C; Lin YC
    Anticancer Res; 2010 Dec; 30(12):5077-84. PubMed ID: 21187493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
    Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V
    Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone-dependent release of transforming growth factor-beta1 from epithelial cells enhances the endometrial decidualization by turning on the Smad signalling in stromal cells.
    Kim MR; Park DW; Lee JH; Choi DS; Hwang KJ; Ryu HS; Min CK
    Mol Hum Reprod; 2005 Nov; 11(11):801-8. PubMed ID: 16403803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transforming growth factor beta1 and dexamethasone on the growth and chondrogenic differentiation of adipose-derived stromal cells.
    Awad HA; Halvorsen YD; Gimble JM; Guilak F
    Tissue Eng; 2003 Dec; 9(6):1301-12. PubMed ID: 14670117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells.
    Gerdes MJ; Dang TD; Larsen M; Rowley DR
    Endocrinology; 1998 Aug; 139(8):3569-77. PubMed ID: 9681509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta1 regulates cell growth and causes downregulation of SMemb/non-muscle myosin heavy chain B mRNA in human prostate stromal cells.
    Obara K; Bilim V; Suzuki K; Kobayashi K; Hara N; Kasahara T; Nishiyama T; Takahashi K
    Scand J Urol Nephrol; 2005; 39(5):366-71. PubMed ID: 16257837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression, activity and regulation of granulocyte macrophage-colony stimulating factor in human endometrial epithelial and stromal cells.
    Chegini N; Tang XM; Dou Q
    Mol Hum Reprod; 1999 May; 5(5):459-66. PubMed ID: 10338369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
    Fromigué O; Marie PJ; Lomri A
    J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function.
    Lu L; Yaszemski MJ; Mikos AG
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S82-91. PubMed ID: 11314800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparate effects of relaxin and TGFbeta1: relaxin increases, but TGFbeta1 inhibits, the relaxin receptor and the production of IGFBP-1 in human endometrial stromal/decidual cells.
    Mazella J; Tang M; Tseng L
    Hum Reprod; 2004 Jul; 19(7):1513-8. PubMed ID: 15155604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFbeta and causing cell cycle arrest.
    Yang L; Ostrowski J; Reczek P; Brown P
    Oncogene; 2001 Nov; 20(55):8025-35. PubMed ID: 11753686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.